000			02042 a2200637 4500
005			20250516125830.0
264		0	_c20130924
008			201309s 0 0 eng d
022			_a1873-7560
024	7		_a10.1016/j.eururo.2012.11.040 _2doi
040			_aNLM _beng _cNLM
100	1		_aMargulis, Vitaly
245	0	0	_aDevelopment of accurate models for individualized prediction of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. _h[electronic resource]
260			_bEuropean urology _cMay 2013
300			_a947-52 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aBiomarkers, Tumor _xblood
650	0	4	_aBlood Transfusion _xmortality
650	0	4	_aCarcinoma, Renal Cell _xblood
650	0	4	_aDecision Support Techniques
650	0	4	_aDisease-Free Survival
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKidney Neoplasms _xblood
650	0	4	_aL-Lactate Dehydrogenase _xblood
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultivariate Analysis
650	0	4	_aNeoplasm Staging
650	0	4	_aNephrectomy _xadverse effects
650	0	4	_aOdds Ratio
650	0	4	_aPatient Selection
650	0	4	_aPrecision Medicine
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Assessment
650	0	4	_aRisk Factors
650	0	4	_aSerum Albumin _xanalysis
650	0	4	_aSerum Albumin, Human
650	0	4	_aTertiary Care Centers
650	0	4	_aTexas
650	0	4	_aTime Factors
650	0	4	_aTransfusion Reaction
650	0	4	_aTreatment Outcome
700	1		_aShariat, Shahrokh F
700	1		_aRapoport, Yury
700	1		_aRink, Michael
700	1		_aSjoberg, Daniel D
700	1		_aTannir, Nizar M
700	1		_aAbel, E Jason
700	1		_aCulp, Stephen H
700	1		_aTamboli, Pheroze
700	1		_aWood, Christopher G
773	0		_tEuropean urology _gvol. 63 _gno. 5 _gp. 947-52
856	4	0	_uhttps://doi.org/10.1016/j.eururo.2012.11.040 _zAvailable from publisher's website
999			_c22378182 _d22378182